LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset (ID:20238)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | BX-912 | 1.11 | uM | LJP5 | 2 | L21 | 72 | hr | 2543 | 2150 | 5578 | 0.3854 | -0.1296 |
| SK-BR-3 | BX-912 | 1.11 | uM | LJP5 | 3 | L21 | 72 | hr | 2543 | 2201 | 5578 | 0.3945 | -0.1128 |
| SK-BR-3 | Canertinib | 1.11 | uM | LJP6 | 1 | H09 | 72 | hr | 2543 | 1766 | 5578 | 0.3166 | -0.2562 |
| SK-BR-3 | Canertinib | 1.11 | uM | LJP6 | 2 | H09 | 72 | hr | 2543 | 1855 | 5578 | 0.3325 | -0.2268 |
| SK-BR-3 | Canertinib | 1.11 | uM | LJP6 | 3 | H09 | 72 | hr | 2543 | 1904 | 5578 | 0.3413 | -0.2107 |
| SK-BR-3 | Celastrol | 1.11 | uM | LJP6 | 1 | G09 | 72 | hr | 2543 | 1834 | 5578 | 0.3288 | -0.2337 |
| SK-BR-3 | Celastrol | 1.11 | uM | LJP6 | 2 | G09 | 72 | hr | 2543 | 1650 | 5578 | 0.2958 | -0.2944 |
| SK-BR-3 | Celastrol | 1.11 | uM | LJP6 | 3 | G09 | 72 | hr | 2543 | 1791 | 5578 | 0.3210 | -0.2479 |
| SK-BR-3 | CGP60474 | 1.11 | uM | LJP5 | 1 | F03 | 72 | hr | 2543 | 1071 | 5578 | 0.1920 | -0.4851 |
| SK-BR-3 | CGP60474 | 1.11 | uM | LJP5 | 2 | F03 | 72 | hr | 2543 | 1123 | 5578 | 0.2013 | -0.4680 |
| SK-BR-3 | CGP60474 | 1.11 | uM | LJP5 | 3 | F03 | 72 | hr | 2543 | 1481 | 5578 | 0.2655 | -0.3500 |
| SK-BR-3 | CGP60474 | 1.11 | uM | LJP6 | 1 | G03 | 72 | hr | 2543 | 1269 | 5578 | 0.2275 | -0.4199 |
| SK-BR-3 | CGP60474 | 1.11 | uM | LJP6 | 2 | G03 | 72 | hr | 2543 | 1052 | 5578 | 0.1886 | -0.4914 |
| SK-BR-3 | CGP60474 | 1.11 | uM | LJP6 | 3 | G03 | 72 | hr | 2543 | 1434 | 5578 | 0.2571 | -0.3655 |
| SK-BR-3 | CHIR-99021 | 1.11 | uM | LJP6 | 1 | P15 | 72 | hr | 2543 | 3469 | 5578 | 0.6218 | 0.3049 |
| SK-BR-3 | CHIR-99021 | 1.11 | uM | LJP6 | 2 | P15 | 72 | hr | 2543 | 4736 | 5578 | 0.8490 | 0.7224 |
| SK-BR-3 | CHIR-99021 | 1.11 | uM | LJP6 | 3 | P15 | 72 | hr | 2543 | 4855 | 5578 | 0.8703 | 0.7616 |
| SK-BR-3 | CP724714 | 1.11 | uM | LJP5 | 1 | A09 | 72 | hr | 2543 | 2709 | 5578 | 0.4856 | 0.0545 |
| SK-BR-3 | CP724714 | 1.11 | uM | LJP5 | 2 | A09 | 72 | hr | 2543 | 2696 | 5578 | 0.4833 | 0.0503 |
| SK-BR-3 | CP724714 | 1.11 | uM | LJP5 | 3 | A09 | 72 | hr | 2543 | 2995 | 5578 | 0.5369 | 0.1488 |
| SK-BR-3 | CP466722 | 1.11 | uM | LJP5 | 1 | I09 | 72 | hr | 2543 | 5946 | 5578 | 1.0658 | 1.1210 |
| SK-BR-3 | CP466722 | 1.11 | uM | LJP5 | 2 | I09 | 72 | hr | 2543 | 5992 | 5578 | 1.0741 | 1.1362 |
| SK-BR-3 | CP466722 | 1.11 | uM | LJP5 | 3 | I09 | 72 | hr | 2543 | 5706 | 5578 | 1.0228 | 1.0420 |
| SK-BR-3 | Crizotinib | 1.11 | uM | LJP5 | 1 | A21 | 72 | hr | 2543 | 4560 | 5578 | 0.8174 | 0.6644 |
| SK-BR-3 | Crizotinib | 1.11 | uM | LJP5 | 2 | A21 | 72 | hr | 2543 | 4443 | 5578 | 0.7964 | 0.6258 |